• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection.

作者信息

Wang Xun, He Xing, Jiang Shujun, Fu Zhangfan, Jiang Shuai, Zhao Xiaoyu, Zhao Chaoyue, Li Yaning, Li Dianfan, Zhang Wenhong, Ai Jingwen, Zhang Yanliang, Xu Chenqi, Wang Pengfei

机构信息

Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai Institute of Infectious Disease and Biosecurity, State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, School of Life Sciences, Fudan University, Shanghai, China.

State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.

出版信息

J Med Virol. 2023 Feb;95(2):e28540. doi: 10.1002/jmv.28540.

DOI:10.1002/jmv.28540
PMID:36722359
Abstract
摘要

相似文献

1
Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection.在SARS-CoV-2 Delta突破性感染后，对原型加强疫苗接种的抗体和B细胞反应增强有限。
J Med Virol. 2023 Feb;95(2):e28540. doi: 10.1002/jmv.28540.
2
Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.最后一剂 COVID-19 疫苗接种时间和完全（加强）接种疫苗的医护人员中的 SARS-CoV-2 突破感染。
J Hosp Infect. 2023 Feb;132:46-51. doi: 10.1016/j.jhin.2022.11.016. Epub 2022 Dec 5.
3
Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections.完全接种疫苗的德尔塔或奥密克戎变异突破感染个体中的 SARS-CoV-2 抗体水平。
Nat Commun. 2022 Aug 1;13(1):4466. doi: 10.1038/s41467-022-32254-8.
4
Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.接种三剂 SARS-CoV-2 mRNA 疫苗后的细胞和体液免疫应答及突破性感染。
Front Immunol. 2022 Aug 17;13:981350. doi: 10.3389/fimmu.2022.981350. eCollection 2022.
5
Association between levels of receptor binding domain antibodies of SARS-CoV-2, receipt of booster and risk of breakthrough infections: LA pandemic surveillance cohort study.SARS-CoV-2 受体结合域抗体水平、加强针接种与突破性感染风险的关联：洛杉矶大流行监测队列研究。
Sci Rep. 2023 Nov 25;13(1):20761. doi: 10.1038/s41598-023-47261-y.
6
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.理解“混合免疫”：对严重急性呼吸综合征冠状病毒 2 感染（SARS-CoV-2）和 2019 年冠状病毒病（COVID-19）疫苗的体液免疫反应的比较和预测因素。
Clin Infect Dis. 2023 Feb 8;76(3):e439-e449. doi: 10.1093/cid/ciac392.
7
Impact of COVID-19 vaccination on transmission risk of breakthrough infections: Lessons from adapted N95 mask sampling for emerging variants and interventions.新冠病毒疫苗接种对突破性感染传播风险的影响：从针对新兴变异株和干预措施的适应性 N95 口罩采样中获得的经验教训。
J Med Virol. 2023 Jan;95(1):e28188. doi: 10.1002/jmv.28188. Epub 2022 Oct 12.
8
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals.接种 BNT162b2 疫苗加强针 5 个月后老年人对 Delta 和奥密克戎变异株特异性抗体滴度的下降
Front Immunol. 2022 Nov 14;13:1031852. doi: 10.3389/fimmu.2022.1031852. eCollection 2022.
9
Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G.利用核衣壳 IgG 对医护人员进行的纵向严重急性呼吸综合征冠状病毒 2 疫苗抗体反应和疫苗突破性感染的鉴定。
J Infect Dis. 2022 Nov 28;226(11):1934-1942. doi: 10.1093/infdis/jiac420.
10
Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections.免疫接种三剂后和突破性 COVID-19 感染前癌症患者 SARS-CoV-2 抗体水平的定量分析。
Curr Oncol. 2022 Sep 28;29(10):7059-7071. doi: 10.3390/curroncol29100554.